MSA - MULTIPLE SYSTEM ATROPHY
Clinical trials for MSA - MULTIPLE SYSTEM ATROPHY explained in plain language.
Never miss a new study
Get alerted when new MSA - MULTIPLE SYSTEM ATROPHY trials appear
Sign up with your email to follow new studies for MSA - MULTIPLE SYSTEM ATROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Nurse-Led video calls aim to ease rare parkinsonism symptoms
Symptom relief OngoingThis study tests whether regular video calls with a specialist nurse can improve daily life for people with atypical parkinsonism (MSA or PSP). About 164 participants will receive home-based telenursing support, including health education and complication monitoring. The goal is …
Matched conditions: MSA - MULTIPLE SYSTEM ATROPHY
Phase: NA • Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Symptom relief
Last updated May 26, 2026 07:51 UTC
-
New hope for MSA patients suffering from severe dizzy spells
Symptom relief OngoingThis study tests a drug called ampreloxetine in about 100 adults with multiple system atrophy (MSA) who also have dangerously low blood pressure when standing up, causing dizziness and fainting. The trial has four phases: first everyone gets the drug, then some are switched to a …
Matched conditions: MSA - MULTIPLE SYSTEM ATROPHY
Phase: PHASE3 • Sponsor: Theravance Biopharma • Aim: Symptom relief
Last updated May 20, 2026 11:55 UTC
-
Mayo clinic launches major study to track brain disease progression
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to learn more about diseases that affect the brain, such as Parkinson's disease and different types of dementia. Researchers will follow 500 adults with symptoms of these conditions, using yearly brain scans and other tests to see how the diseases change over time…
Matched conditions: MSA - MULTIPLE SYSTEM ATROPHY
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC